Intermittent oral disodium pamidronate in established osteoporosis: A 2 year double-masked placebo-controlled study of efficacy and safety

Medicine and Dentistry

• Osteoporosis 100%
• Pamidronic Acid 100%
• Placebo-Controlled Study 100%
• Bone Density 66%
• Placebo 66%
• Vitamin D 33%
• Isotopes of Calcium 33%
• Analysis of Variance 33%
• Urinary System 33%
• Scanning Electron Microscopy 33%
• Dual-Energy X-Ray Absorptiometry 33%
• Deoxypyridinoline 33%
• Adverse Event 33%
• Intention-to-Treat Analysis 33%
• Osteocalcin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo-Controlled Study 100%
• Pamidronic Acid 100%
• Placebo 66%
• Scanning Electron Microscopy 33%
• Adverse Event 33%
• Vitamin D 33%
• Osteocalcin 33%
• Deoxypyridinoline 33%